Influence of resveratrol on the cardiovascular health effects of chronic kidney disease

Jenn Yeu Song, Ta Chung Shen, Yi Chou Hou, Jia Feng Chang, Chien Lin Lu, Wen Chih Liu, Po Jui Chen, Bo Hau Chen, Cai Mei Zheng, Kuo Cheng Lu

研究成果: 雜誌貢獻回顧型文獻同行評審

13 引文 斯高帕斯(Scopus)


Cardiovascular disease (CVD) is closely related to chronic kidney disease (CKD), and patients with CKD have a high risk of CVD-related mortality. Traditional CVD risk factors cannot account for the higher cardiovascular risk of patients with CKD, and standard CVD interventions cannot reduce the mortality rates among patients with CKD. Nontraditional factors related to mineral and vitamin-D metabolic disorders provide some explanation for the increased CVD risk. Non-dialyzable toxins, indoxyl sulfate (IS) and p-cresol sulfate (PCS)—produced in the liver by colonic microorganisms—cause kidney and vascular dysfunction. Plasma trimethylamine-N-oxide (TMAO)—a gut microbe-dependent metabolite of dietary L-carnitine and choline—is elevated in CKD and related to vascular disease, resulting in poorer long-term survival. Therefore, the modulation of colonic flora can improve prospects for patients with CKD. Managing metabolic syndrome, anemia, and abnormal mineral metabolism is recommended for the prevention of CVD in patients with CKD. Considering nontraditional risk factors, the use of resveratrol (RSV), a nutraceutical, can be helpful for patients with CVD and CKD. This paper discusses the beneficial effects of RSV on biologic, pathophysiological and clinical responses, including improvements in intestinal epithelial integrity, modulation of the intestinal microbiota and reduction in hepatic synthesis of IS, PCS and TMAO in patients with CVD and CKD.
頁(從 - 到)1-16
期刊International journal of molecular sciences
出版狀態已發佈 - 9月 1 2020

ASJC Scopus subject areas

  • 催化
  • 分子生物學
  • 光譜
  • 電腦科學應用
  • 物理與理論化學
  • 有機化學
  • 無機化學


深入研究「Influence of resveratrol on the cardiovascular health effects of chronic kidney disease」主題。共同形成了獨特的指紋。